This result was in line with the features of TREM2+ MФs in Alzheimer's disease (AD) and obesity-related metabolic syndrome 7, 11, suggesting their potential pro-resolving property in skin fibrosis. This evidence concerns the gene TREM2 and early-onset autosomal dominant Alzheimer disease.